Group One Trading, L.P. Exelixis, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$20.17 - $23.93 $4.11 Million - $4.87 Million	-203,610 Reduced 99.6%	817 $19,000
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $428,620 - $537,278	22,266 Added 12.22%	204,427 $4.9 Million
Q3 2023 Nov 09, 2023	SELL	$19.04 - $22.74 $19,992 - $23,877	-1,050 Reduced 0.57%	182,161 $3.98 Million
Q2 2023 Aug 09, 2023	BUY	$18.17 - $20.48 $2.75 Million - $3.1 Million	151,249 Added 473.22%	183,211 $3.5 Million
Q1 2023 May 12, 2023	BUY	$16.3 - $19.41 $12,779 - $15,217	784 Added 2.51%	31,962 $620,000
Q4 2022 Feb 09, 2023	BUY	$14.96 - $17.39 $80,843 - $93,975	5,404 Added 20.97%	31,178 $500,000
Q3 2022 Nov 09, 2022	SELL	$15.68 - $22.27 $13,908 - $19,753	-887 Reduced 3.33%	25,774 $404,000
Q2 2022 Aug 11, 2022	SELL	$17.44 - $23.16 $263,675 - $350,156	-15,119 Reduced 36.19%	26,661 $555,000
Q1 2022 May 12, 2022	SELL	$17.03 - $22.67 $27,963 - $37,224	-1,642 Reduced 3.78%	41,780 $947,000
Q4 2021 Feb 11, 2022	SELL	$15.84 - $21.88 $33,359 - $46,079	-2,106 Reduced 4.63%	43,422 $794,000
Q3 2021 Nov 12, 2021	BUY	$16.3 - $21.14 $569,815 - $739,012	34,958 Added 330.73%	45,528 $962,000
Q2 2021 Aug 10, 2021	BUY	$17.95 - $25.56 $189,731 - $270,169	10,570 New	10,570 $193,000
Q1 2020 May 13, 2020	SELL	$14.46 - $21.8 $1.41 Million - $2.12 Million	-97,226 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$15.15 - $18.89 $309,908 - $386,413	-20,456 Reduced 17.38%	97,226 $1.71 Million
Q3 2019 Nov 12, 2019	BUY	$17.68 - $22.65 $2.08 Million - $2.67 Million	117,682 New	117,682 $2.08 Million
Q1 2019 May 13, 2019	SELL	$19.6 - $24.76 $2.41 Million - $3.04 Million	-122,753 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$13.65 - $21.8 $84,152 - $134,397	6,165 Added 5.29%	122,753 $2.42 Million
Q3 2018 Nov 08, 2018	BUY	$15.87 - $22.4 $140,512 - $198,329	8,854 Added 8.22%	116,588 $2.07 Million
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $198,332 - $239,900	10,686 Added 11.01%	107,734 $2.32 Million
Q1 2018 May 11, 2018	SELL	$22.15 - $31.89 $8.04 Million - $11.6 Million	-362,911 Reduced 78.9%	97,048 $2.15 Million
Q4 2017 Feb 09, 2018	BUY	$24.23 - $30.93 $1.54 Million - $1.97 Million	63,598 Added 16.05%	459,959 $14 Million
Q3 2017 Nov 15, 2017	BUY	$23.35 - $29.24 $3.32 Million - $4.15 Million	142,081 Added 55.88%	396,361 $9.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	254,280	254,280 $6.26 Million

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account